Brief: Surface Oncology Says Co Applied To Transfer Listing Of Common Stock From Nasdaq Global Market To Nasdaq Capital Market On June 28
10/07/2023 11:24
July 10 (Reuters) - Surface Oncology Inc SURF.O :
* SURFACE ONCOLOGY INC - ON JUNE 28, 2023, COMPANY APPLIED
TO
TRANSFER LISTING OF COMMON STOCK FROM NASDAQ GLOBAL MARKET TO
NASDAQ CAPITAL MARKET
* SURFACE ONCOLOGY INC - ON JULY 6, 2023, NASDAQ NOTIFIED
COMPANY
THAT TRANSFER WAS APPROVED
* SURFACE ONCOLOGY INC - EFFECTIVE AT OPENING OF BUSINESS ON
JULY
10, 2023, COMMON STOCK WILL BE TRANSFERRED TO NASDAQ CAPITAL
MARKET
* SURFACE ONCOLOGY INC - COMMON STOCK WILL CONTINUE TO TRADE
UNDER
SYMBOL "SURF."
Further company coverage: SURF.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Surface Oncology
See all newsBrief: Surface Oncology Says Anticipates Will Have Net Cash Of $20 Million To $25 Million At The Closing Of The Proposed Mergers
Surface Oncology Inc reports results for the quarter ended in June - Earnings Summary
Brief: Surface Oncology, Inc. Q2 Net Income USD -28.2 Mln
Surface Oncology Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: ADAR1 Partners Reports 5.24% Passive Stake In Surface Oncology Inc As Of July 10 - SEC Filing